This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Penn Medicine at the International Congress of Parkinson's Disease and Movement Disorders

June 9th, 2014

Penn Medicine researchers will be among the featured presenters at the 18th International Congress of Parkinson's Disease and Movement Disorders in Stockholm, Sweden, from Sunday, June 8 to Thursday, June 12, 2014.

Matthew Stern, MD, director of the Parkinson's Disease and Movement Disorders Center in the Department of Neurology and current president of the International Parkinson's Disease and Movement Disorders Society, will chair a plenary session entitled "New insights into the pathology, progression, and heterogeneity of Parkinson's disease."

John Q. Trojanowski, MD, PhD, director of the Penn Institute on Aging and Center for Neurodegenerative Disease Research co-director, will describe the latest animal models that recapitulate the different alpha-synuclein pathologies in Parkinson's disease (PD) (Abstract #898).

Virginia M.Y. Lee, PhD, CNDR director, will present the use of how these PD animal models are being used in preclinical studies to test the efficacy of immunotherapy as well as to understand how the different types of alpha-synuclein pathologies may be responsible for the variations in the clinical presentations of PD (Abstract #56).

Provided by University of Pennsylvania School of Medicine

Citation: Penn Medicine at the International Congress of Parkinson's Disease and Movement Disorders (2014, June 9) retrieved 28 March 2024 from https://sciencex.com/wire-news/163768659/penn-medicine-at-the-international-congress-of-parkinsons-diseas.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.